当前位置: X-MOL 学术ACS Med. Chem. Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity
ACS Medicinal Chemistry Letters ( IF 4.2 ) Pub Date : 2017-07-31 00:00:00 , DOI: 10.1021/acsmedchemlett.7b00222
Chengbin Yang 1 , Xi Zhang 2 , Yi Wang 2 , Yongtai Yang 1 , Xiaofeng Liu 1 , Mingli Deng 1 , Yu Jia 1 , Yun Ling 1 , Ling-hua Meng 2 , Yaming Zhou 1
Affiliation  

The phosphoinositide 3-kinase (PI3K) inhibitors potently inhibit the signaling pathway of PI3K/AKT/mTOR, which provides a promising new approach for the molecularly targeted cancer therapy. In this work, a novel series of 7-azaindole scaffold derivatives was discovered by the fragment-based growing strategy. The structure–activity relationship profiles identified that the 7-azaindole scaffold derivatives exhibit potent activity against PI3K at molecular and cellular levels as well as cell proliferation in a panel of human tumor cells.

中文翻译:

发现具有活性的PI7K抑制剂的新型7-氮杂吲哚骨架衍生物系列。

磷酸肌醇3-激酶(PI3K)抑制剂有效抑制PI3K / AKT / mTOR的信号传导途径,这为分子靶向癌症治疗提供了一种有希望的新方法。在这项工作中,通过基于片段的生长策略发现了一系列新型的7-氮杂吲哚支架衍生物。结构-活性之间的关系曲线表明,7-氮杂吲哚支架衍生物在分子和细胞水平上均表现出对PI3K的有效活性,并在一组人类肿瘤细胞中表现出细胞增殖作用。
更新日期:2017-07-31
down
wechat
bug